As small-molecule CDMOs pivot their businesses to meet the demands of the life science sector, I spoke with CEO & Founder Tia Lyles-Williams to find out what this really means for the industry. Click to find out more.
What are organisations doing to improve diversity in clinical trials? Click to find out what a panel of CRO leaders had to say in our latest live webinar. Now available as a podcast.
.jpg)
In this episode of CM Conversations, our guest share his tips on hitting the ground running and building a team remotely, as well as the importance of investing in relationships. In his words, you should always be visible and available.
In the US, New Jersey is a life science powerhouse. It’s home to some of the most influential pharma manufacturers in the world. Click to find out some of the latest developments coming from this area.
In this clip, I talk about how acting fast is crucial to securing the very best talent in life sciences.
.jpg)
In this clip, I discuss the skills and people that are in demand within the life science industry.
.jpg)
In this clip, I talk about how small companies can beat the larger corporations for talent. They just need to show off what makes them different, that they're people-focused and they can be flexible.
In this live episode, join life science recruitment experts Eleanor Doolin and Adam Butler as they discuss how the best businesses from across the life science space are winning the war for talent.
Special purpose acquisition companies, or SPACs, have recently emerged onto the investment scene at a rapid rate. They are an unconventional means of taking a company public but becoming increasingly popular. Are SPACs really here to stay?
I've collaborated with multiple experts at major small molecule CDMOs to talk about the impact that biologics has has on their industry. This article featured in the industry leading publication, Speciality Chemicals Magazine.
Demand for biologics is at an all-time high, which has forced businesses to majorly invest in manufacturing and production.
.jpg)
There’s optimism throughout all the markets we serve and to celebrate this we asked our CM Life Science team what they think we can expect from the year ahead in life sciences. Here's what they said...
We are undergoing the biggest vaccination program in history, aiming to finally bring the COVID-19 pandemic to an end. This presents pharmacovigilance’s with its biggest test yet.
.jpg)
With such a strong 2019, 2020 was expected to be a ‘mega year’ for life science companies with a reported $1.4 trillion in firepower at their disposal for M&As. However, COVID-19 gave us an unexpected twist.
.jpg)
What does AI mean for drug discovery? This question and many others was answered by three AI experts in our latest CM Life Science webinar.
For this episode of CM Conversations, our Director of Operations Tom Maskill spoke with QIAGEN CEO Thierry Bernard.
In my line of work you come across new companies everyday, however, few are as forward-thinking and unique as Norman Health. I spoke to the company's founder and Managing Director, Jan-Wilem Eleveld.
For decades, we’ve been talking about how NGS will change the world. But what if NGS was only the start?
Prejudice is rife in 2020 (both conscious and unconscious), so it’s crucial that we educate ourselves. It’s never been so important to embrace Black History Month.
.jpg)
Only 30% of executive positions and 18% of board seats are held by women in biotech. I spoke to an industry expert, Melissa Gammell, to find out where we're going wrong, how we get more women into biotech and how we keep them there.
In this episode of CM Conversations, our lab equipment specialist Lucy Smith spoke with Melissa Gammell, Vice President of Business Development at Matphil Technologies about the challenges facing women in biotech.
.jpg)
In this episode, our specialist in the lab equipment space, Lucy Smith, spoke with CEO of Elementar Americas Ryan Titmas. Lucy spoke to Ryan about what it takes to get to the top, as well as some of the lessons he’s learned in his career so far.
As businesses prioritise the wellbeing of their employees, the concept of working a 4 day week is shifting from distant pipedream to reality for a range of organisations around the world.
Even if you’ve been through the process, you may not be aware of exactly what goes into M&A deals. Today, we’ve tried to look into that in a little more detail with Transaction Liability Team Leader Grant Hollis from CFC Underwriting,
Coronavirus has provided us with a very large and extremely recent data set for research, patient populations and how different ethnic minorities are being affected versus the research. And the early indicators are that those from minority background
The approach to fighting coronavirus has not differed to the fight against any other outbreak in terms of what is required to control it.
One of the biggest partnering events in the life science calendar Bio-Europe Spring, was scheduled to take place in Paris from March 23 – 27 this year. That all changed with the emergence of COVID-19...
Returning from CPhI 2019, in Frankfurt, the words of Eric Langer, President of Bioplan Associates, have stuck with me. Forget the innovation, are biosimilars the real 'workhorse' carrying biopharma to bigger and better things?
Pharma packaging is in transition. Companies are now pushing boundaries, furthering their offerings and innovating to be seen as true healthcare partners.
I’ve lost count of the times I’ve seen ‘PhD preferred’, while recruiting for positions in R&D and product development. In the modern life science talent market, are PhDs really so important?
I’ve lost count of the times I’ve seen ‘PhD preferred’, while recruiting for positions in R&D and product development. In the modern life science talent market, are PhDs really so important?
Our Principal Consultant, Adam Butler, talks about the miracles of Stem Cell therapy, the issues surrounding it and the most high-profile case in the treatments' existence.
In an industry as fast paced as the specialty chemicals sector, it's almost impossible to predict the future, but we wanted to try.
Identifying the next big trend in a market like specialty chemicals can be gold dust for any company or individual savvy enough to see it.
In today's hyper-connected world, what's the point of conferences? Our Associate Director Jack Shute asked experts from across the speciality chemical space and some of his CM Life Science colleagues to find out.
It’s no secret that pharmaceutical manufacturing has been on the rise in the East, with both China and India emerging as major manufacturing hubs.
The diverse and complex world of Pharmaceuticals and Contract Development and Manufacturing Organization (CDMO) is undergoing a fascinating transition.
There are a lot of people and organisations who rank Contract/Clinical Research Organisations. Not only that, but they do it extremely well. That’s why the tables and rankings that appear so regularly on our newsfeeds are so popular.
